๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

โœ Scribed by K. Yamamoto; Y. Kikuchi; K. Kudoh; I. Nagata


Publisher
Springer-Verlag
Year
2000
Tongue
English
Weight
171 KB
Volume
126
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Radiotherapy as a cisplatin-sensitizer i
โœ David F. Silver; Clifford R. Wheeless Jr.; Norman H. Dubin ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB

## BACKGROUND. Stage 111 ovarian carcinoma has shown resistance to adjuvant chemotherapy following surgical cytoreduction. With recurrence of ovarian carcinoma, cell lines may develop resistance to previously used chemotherapy. This contributes to the fact that survival rates for patients with ova

Modulation of cisplatin sensitivity and
โœ Vicram Gupta; Jitesh P. Jani; Erling O. Emerson; Bing H. Xu; Domenic Scalamogna; ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 593 KB

## Abstract This study was undertaken to elucidate the mechanism(s) of potentiation of cisplatin (CDDP) cytotoxicity by interferon ฮฑโ€2a (IFN ฮฑโ€2a) in human squamous carcinoma cell lines SCCโ€25 and SCCโ€4. IFN ฮฑโ€2a treatment significantly increased the cytotoxicity of CDDP in both cell lines in a dos